NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity.
The goal of this program is to improve management of biofilms in urologic practice, management of perceived bladder pain, and treatment of high-risk non-muscle invasive bladder cancer. After hearing and assimilating this program, the clinician will be better able to:
1. Optimize management of an encrusted stent in urologic procedures.
2. Compare different phenotypes of perceived bladder pain.
3. Administer intravesical therapy in patients with bladder-specific pain symptoms.
4. Use bacillus Calmette-Guerin (BCG) therapy in a patient with non-muscle invasive bladder cancer.
5. Differentiate BCG late relapse from BCG intolerance in high-risk non-muscle invasive bladder cancer.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Urology
- Start Date: 2022-12-13 06:00:00
- End Date: 2022-12-13 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all